Welcome to CDC stacks | Treatment of Giardiasis after Nonresponse to Nitroimidazole - 25653 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Treatment of Giardiasis after Nonresponse to Nitroimidazole
Filetype[PDF-295.82 KB]


Details:
No Related Documents.
You May Also Like:
  1. Trichomonas vaginalis: treatment questions and challenges
    Personal Author:
    Secor, W Evan
    Published:
    Feb 2012
    Source:
    Expert Rev Anti Infect Ther. 10(2):107-109.
    File Type:
    Filetype[PDF - 57.46 KB]
  2. Giardiasis Diagnosis and Treatment Practices Among Commercially Insured Persons in the United States
    Personal Author:
    Beer, Karlyn D.; Collier, Sarah A.; Du, Fan; Gargano, Julia W.;
    Published:
    May 01 2017
    Source:
    Clin Infect Dis. 64(9):1244-1250.
    Description:
    Background : Giardiasis, the most common enteric parasitic infection in the United States, causes an estimated 1.2 million episodes of illness annually. Published clinical recommendations include readily available Giardia-specific diagnostic testing ...
    File Type:
    Filetype[PDF - 414.31 KB]
  3. Trichomonas vaginalis Antimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009–2010
    Personal Author:
    Kirkcaldy, Robert D.; Augostini, Peter; Asbel, Lenore E.; Bernstein, Kyle T.; Kerani, Roxanne P.; Mettenbrink, Christie J.; Pathela, Preeti; Schwebke, Jane R.; Secor, W. Evan; Workowski, Kimberly A.; Davis, Darlene; Braxton, Jim; Weinstock, Hillard S.;
    Published:
    Jun 2012
    Source:
    Emerg Infect Dis. 18(6):939-943.
    Description:
    Nitroimidazoles (metronidazole and tinidazole) are the only recommended drugs for treating Trichomonas vaginalis infection, and previous samples that assessed resistance of such isolates have been limited in geographic scope. We assessed the prevalen...
    File Type:
    Filetype[PDF - 333.39 KB]
  4. Zika Virus Infection in Patient with No Known Risk Factors, Utah, USA, 2016
    Personal Author:
    Krow-Lucal, Elisabeth R.; Novosad, Shannon A.; Dunn, Angela C.; Brent, Carolyn R.; Savage, Harry M.; Faraji, Ary; Peterson, Dallin; Dibbs, Andrew; Vietor, Brook; Christensen, Kimberly; Laven, Janeen J.; Godsey, Marvin S.; Christensen, Bryan; Beyer, Brigette; Cortese, Margaret M.; Johnson, Nina C.; Panella, Amanda J.; Biggerstaff, Brad J.; Rubin, Michael; Fridkin, Scott K.; Staples, J. Erin; Nakashima, Allyn K.;
    Published:
    Aug 2017
    Source:
    Emerg Infect Dis. 23(8):1260-1267.
    Description:
    In 2016, Zika virus disease developed in a man (patient A) who had no known risk factors beyond caring for a relative who died of this disease (index patient). We investigated the source of infection for patient A by surveying other family contacts, ...
    File Type:
    Filetype[PDF - 1.04 MB]
  5. Neglected Parasitic Infections in the United States: Trichomoniasis
    Personal Author:
    Secor, W. Evan; Meites, Elissa; Starr, Michelle C.; Workowski, Kimberly A.;
    Published:
    May 2014
    Source:
    Am J Trop Med Hyg. 2014; 90(5):800-804.
    Description:
    Trichomonas vaginalis is one of the most common human parasitic infections in the United States, as well as the most prevalent non-viral sexually transmitted infection. However, it has long received much less consideration than other parasitic and se...
    File Type:
    Filetype[PDF - 465.17 KB]